Is BIOVIE INC. (BIVI) Halal?
Shariah Screening — 5 Standards
Based on financial data from June 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 3.4% / 30% | 171.1% / 30% | 20.5% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 3.4% / 33% | 171.1% / 33% | 20.5% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 1.6% / 33% | 81.4% / 33% | 9.8% / 33% | N/A | ✗ NOT HALAL |
| S&P | 3.4% / 33% | 171.1% / 33% | 20.5% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 1.6% / 33% | 81.4% / 33% | 9.8% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -80.7% | |
| Return on Assets (ROA) | -47.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$19M |
| Free Cash Flow | -$19M |
| Total Debt | $349,894 |
| Debt-to-Equity | 1.6 |
| Current Ratio | 7.2 |
| Total Assets | $22M |
Price & Trading
| Last Close | $1.36 |
| 50-Day MA | $1.28 |
| 200-Day MA | $2.88 |
| Avg Volume | 110K |
| Beta | 0.6 |
|
52-Week Range
$1.06
| |
About BIOVIE INC. (BIVI)
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is BIOVIE INC. (BIVI) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), BIOVIE INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is BIOVIE INC.'s debt ratio?
BIOVIE INC.'s debt ratio is 3.4% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 1.6%.
What are BIOVIE INC.'s key financial metrics?
BIOVIE INC. has a market capitalization of $10M. Return on equity stands at -80.7%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.